Prestige BioPharma Limited (950210.KS)

KRW 15050.0

(-4.57%)

Annual Balance Sheets

(In KRW)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 711.72 Billion 741.6 Billion 499.81 Billion 604.16 Billion 160.09 Billion 102.92 Billion
Total Current Assets 250.35 Billion 311.47 Billion 311.56 Billion 459.93 Billion 49.81 Billion 20.03 Billion
Cash And Short Term Investments 228.81 Billion 301.41 Billion 303.26 Billion 459.35 Billion 48.39 Billion 9.82 Billion
Cash and Cash Equivalents 219.43 Billion 125.02 Billion 268.65 Billion 458.97 Billion 45.97 Billion 9.82 Billion
Short Term Investments 9.38 Billion 176.39 Billion 34.61 Billion 377.68 Million 2.42 Billion -
Net Receivables 3.43 Billion 133.21 Million - 649.55 Million 2.42 Billion 1.95 Billion
Inventory 18.1 Billion 7.14 Billion 2.15 Billion -155.87 Million -2.42 Billion 1.00
Other Current Assets -1000.00 21.36 Billion 6.13 Billion 90.4 Million 1.41 Billion 8.25 Billion
Total Non-Current Assets 461.36 Billion 430.12 Billion 188.24 Billion 144.22 Billion 110.28 Billion 82.89 Billion
Net PPE 327.06 Billion 310.43 Billion 38.34 Billion 6.43 Billion 4.51 Billion 1.04 Billion
Good Will And Intangible Assets 133.75 Billion 118.91 Billion 65.31 Billion 109.02 Billion 95.01 Billion 68.26 Billion
Good Will 10.78 Billion 10.19 Billion - - - -
Intangible Assets 122.97 Billion 108.71 Billion 65.31 Billion 109.02 Billion 95.01 Billion 68.26 Billion
Long-Term Investments -8.82 Billion -175.61 Billion 40.09 Billion 23.78 Billion 6.91 Billion 9.28 Billion
Tax Assets - - 34.61 Billion 3.55 Billion 2.42 Billion 1.51
Other Non Current Assets 9.38 Billion 176.39 Billion 9.88 Billion 1.42 Billion 1.42 Billion 4.29 Billion
Other Assets - - - -1000.00 1000.00 -
Total Liabilities 196.21 Billion 195.36 Billion 69.87 Billion 29.2 Billion 22.29 Billion 44.73 Billion
Total Current Liabilities 145.85 Billion 134.88 Billion 41.79 Billion 14.04 Billion 8.47 Billion 33.76 Billion
Account Payables 2.28 Billion 462.14 Million 2.62 Billion -563.07 Million -231.91 Million 1.00
Tax Payables - - 632.31 Million - - -
Short Term Debt 48.79 Billion 32.85 Billion 1.59 Billion 4.19 Billion 443.83 Million 18.47 Billion
Deferred Revenue 45.44 Billion 100.02 Billion 34.12 Billion 563.07 Million 231.91 Million 1.71 Billion
Other Current Liabilities 49.33 Billion 1.54 Billion 3.45 Billion 9.84 Billion 8.03 Billion 13.58 Billion
Total Non Current Liabilities 50.36 Billion 60.47 Billion 28.08 Billion 15.15 Billion 13.82 Billion 10.96 Billion
Long-Term Debt 40.87 Billion 51.51 Billion 2.65 Billion 3.57 Billion 2.43 Billion 48.11 Million
Deferred Revenue Non Current - 1.59 Billion 25.42 Billion 11.58 Billion 11.38 Billion 10.91 Billion
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.73 Billion 1000.00 1000.00 1000.00 - 10.41 Million
Other Liabilities - - - -1000.00 - -
Total Equity 515.5 Billion 546.23 Billion 429.93 Billion 574.96 Billion 137.79 Billion 58.18 Billion
Stock Holders Equity 439.08 Billion 450.51 Billion 429.93 Billion 574.96 Billion 137.79 Billion 58.18 Billion
Common Stock 730.34 Billion 690.17 Billion 679.71 Billion 594.07 Billion 152.77 Billion 61.42 Billion
Retained Earnings -294.79 Billion -246.15 Billion -259.6 Billion -27.95 Billion -21.89 Billion -6.56 Billion
Accumulated other comprehensive income -4.28 Billion 6.51 Billion 9.86 Billion 8.81 Billion 6.92 Billion 3.33 Billion
Common Stock Equity 439.08 Billion 450.51 Billion 429.93 Billion 574.96 Billion 137.79 Billion 58.18 Billion
Capital Lease Obligation 1.57 Billion 3 Billion 4.24 Billion 4.89 Billion 2.81 Billion -
Total Investments 551.5 Million 775.14 Million 74.71 Billion 24.15 Billion 9.33 Billion 9.28 Billion
Total Debt 89.66 Billion 84.37 Billion 4.24 Billion 7.77 Billion 2.87 Billion 18.52 Billion
Net Debt -129.76 Billion -40.64 Billion -264.4 Billion -451.2 Billion -43.09 Billion 8.69 Billion

Balance Sheet Charts